New pill aims to ease heavy periods from fibroids
NCT ID NCT07319520
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This Phase 2 trial tested an oral drug called DW4902 in 71 premenopausal women with uterine fibroids and heavy menstrual bleeding. Participants took either a placebo or one of three doses of DW4902 daily for 12 weeks. The main goal was to see if the drug could reduce bleeding to near-normal levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DW4902 (oral drug)
- What this could lead to
- If successful, this could lead to a non-surgical treatment option for heavy menstrual bleeding caused by uterine fibroids.
- What could go wrong
- This is an early Phase 2 trial with only 71 participants, so results may not be conclusive. The drug may not work better than placebo or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOMA OF UTERUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
Seoul, South Korea